查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750647

全球 DNA 编码库市场规模、份额和趋势分析报告：按产品/服务、治疗领域、应用、最终用途、地区和细分市场预测 2025-2030 年

DNA-encoded Library Market Size, Share & Trends Analysis Report By Product & Service, By Therapeutic Area, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

DNA编码库市场的成长与趋势：

根据 Grand View Research, Inc. 的最新报告，全球 DNA 编码库市场预计到 2030 年将达到 16 亿美元，2025 年至 2030 年的复合年增长率为 13.4%。

对新型标靶药物研发日益增长的需求是推动市场成长的主要因素之一。这些库能够对大量化合物进行高通量筛检，从而大大加快潜在候选药物的鑑定速度。传统的化合物筛检方法可能耗时且耗力，但DNA编码库透过将独特的DNA序列附加到每种化合物上，简化了这一过程，从而能够同时快速识别和评估大量候选化合物。这种效率在药物研发中是一项巨大的优势，因为速度和准确性至关重要。

推动DNA编码库产业发展的另一个关键因素是对精准医疗日益增长的关注。随着医疗保健产业朝着更个人化的治疗方向发展，发现特异性针对个人基因谱的药物的能力变得越来越重要。 DNA编码库提供了一种独特的解决方案，它能够创建针对特定疾病途径或患者群体的高度多样化的库。这在肿瘤学和遗传疾病领域尤其有益，因为个人化治疗有望改善这些领域的治疗效果。

癌症、自体免疫疾病和感染疾病等慢性疾病的盛行率不断上升，也推动了市场的成长。这些疾病在全球日益加重，这加速了对药物研发技术的投资，这些技术可以加快有效治疗方法的发展。 DNA编码库在这一领域发挥关键作用，它有助于发现新型小分子、抗体和其他生技药品，从而有可能满足尚未满足的医疗需求。尤其是，人们对抗体和免疫疗法日益增长的兴趣，凸显了DNA编码库等高效药物研发方法的重要性。

基因组学和生物资讯学的技术进步进一步推动了市场的成长。定序技术的进步及其成本效益提高了建构大型、高度多样化DNA编码库的能力。生物资讯工具的整合也提高了分析复杂数据的能力，使研究人员能够优化候选化合物的选择，并提高药物发现过程的效率。这些进步使得DNA编码库更易于取得且更有效率，从而促进了其在製药和生物技术公司的应用。

此外，製药公司、学术机构和受託研究机构之间日益增多的合作与伙伴关係也推动了市场扩张。这些合作促进了资源和专业知识的共用，加速了DNA编码化合物库技术在药物研发中的开发和应用。由于突破性药物的潜力仍然巨大，公共和私人资金的不断增加也为市场提供了支持。这些因素共同为DNA编码化合物库市场的成长和扩张创造了有利环境。

DNA编码库市场报告重点

  • 由于药物发现研究外包的增加，该服务部门预计将引领 DNA 编码库产业并在 2024 年产生最高收益。
  • 根据治疗领域，肿瘤学领域在 2024 年占据最大收入份额，为 38.32%。
  • 根据应用，由于对高效的先导化合物发现解决方案的需求不断增长，命中生成/识别部分在 2024 年占据了 42.52% 的份额。
  • 根据最终用途，製药和生物技术公司在 2024 年占据最大的收益占有率，为 42.77%。
  • DNA编码库市场由北美主导，这主要归功于其生物技术部门和强劲的製药业。

目录

第一章调查方法与范围

第二章执行摘要

3. DNA编码库市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • DNA编码库市场分析工具
    • 产业分析：波特五力分析
    • PESTEL分析
    • COVID-19影响分析

4. DNA编码图书馆市场：产品和服务估计和趋势分析

  • 产品/服务细分仪表板
  • 全球 DNA 编码库市场：产品与服务差异分析
  • 2018-2030年全球DNA编码库市场规模及趋势分析（依产品及服务）
  • 产品
    • 产品市场规模、预测及趋势分析（2018-2030年）
    • 套件和试剂
    • 编码库
    • 其他的
  • 服务
    • 服务市场规模、预测与趋势分析（2018-2030年）
    • 设计与合成服务
    • 筛检服务
    • 其他的

第五章 DNA 编码库市场：治疗领域估计与趋势分析

  • 治疗领域细分仪表板
  • 全球DNA编码库市场：依治疗领域的变异分析
  • 2018-2030年全球DNA编码库市场规模及治疗领域趋势分析
  • 肿瘤学
    • 肿瘤学市场规模、预测与趋势分析（2018-2030年）
  • 感染疾病
    • 感染疾病市场规模、预测与趋势分析（2018-2030年）
  • 心血管疾病
    • 心血管疾病市场规模、预测与趋势分析（2018-2030年）
  • 神经系统疾病
    • 神经系统疾病市场规模、预测与趋势分析（2018-2030年）
  • 自体免疫疾病
    • 自体免疫疾病市场规模、预测与趋势分析（2018-2030）
  • 代谢疾病
    • 代谢疾病市场规模、预测与趋势分析（2018-2030）
  • 其他的
    • 其他市场规模、预测和趋势分析（2018-2030年）

第六章 DNA编码库市场：应用评估与趋势分析

  • 应用程式细分仪表板
  • 全球DNA编码库市场：应用变异分析
  • 2018-2030年全球DNA编码库市场规模及应用趋势分析
  • 命中生成/识别
    • 命中生成/识别市场规模、预测和趋势分析（2018-2030 年）
  • Hit to Lead（H2L）
    • 热门产品 (H2L) 市场规模、预测与趋势分析（2018-2030 年）
  • 命中检验/优化
    • 命中检验/优化市场规模、预测和趋势分析（2018-2030）
  • 其他的
    • 其他市场规模、预测和趋势分析（2018-2030年）

7. DNA编码库市场：最终用途预估与趋势分析

  • 最终用途细分仪表板
  • 全球 DNA 编码库市场：最终用途变异分析
  • 2018-2030年全球DNA编码库市场规模及趋势分析（依最终用途）
  • 学术研究所
    • 学术研究机构市场规模、预测与趋势分析（2018-2030 年）
  • 製药和生物技术公司
    • 製药和生物技术公司的市场规模、预测和趋势分析（2018-2030 年）
  • 合约研究组织
    • 合约研究组织市场规模、预测与趋势分析（2018-2030 年）
  • 其他的
    • 其他市场规模、预测和趋势分析（2018-2030年）

8. DNA编码库市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 参与企业
  • 2024年企业市场分析
  • 战略地图
  • 参与企业概况
    • Merck KGaA
    • GenScript
    • Pharmaron
    • WuXi Biology
    • Aurigene Pharmaceutical Services
    • BOC Sciences
    • LGC Bioresearch Technologies
    • SPT Labtech Ltd
    • Life Chemicals
    • Charles River Laboratories
Product Code: GVR-4-68040-564-5

DNA-encoded Library Market Growth & Trends:

The global DNA-encoded library market size is expected to reach USD 1.60 billion by 2030, growing at a CAGR of 13.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising demand for novel and targeted drug discovery is one of the key factors driving the market growth. These libraries enable high-throughput screening of vast chemical compounds, significantly accelerating the identification of potential drug candidates. Traditional methods for screening chemical compounds can be time-consuming and resource-intensive, but DNA-encoded libraries streamline this process by attaching a unique DNA sequence to each compound, making it possible to rapidly identify and evaluate numerous candidates simultaneously. This efficiency is a major advantage in drug discovery, where speed and accuracy are critical.

Another significant factor propelling the growth of the DNA-encoded library industry is the increasing focus on precision medicine. As the healthcare industry moves toward more personalized treatments, the ability to discover drugs that specifically target individual genetic profiles becomes more valuable. DNA-encoded libraries offer a unique solution by enabling the creation of highly diverse libraries that can be tailored to target specific disease pathways or patient populations. This is particularly beneficial in the fields of oncology and genetic disorders, where personalized therapies have shown great promise in improving treatment outcomes.

The rising prevalence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, is also contributing to the market growth. The increasing burden of these diseases worldwide has spurred investments in drug discovery technologies that can lead to faster development of effective treatments. DNA-encoded libraries play a critical role in this by facilitating the discovery of novel small molecules, antibodies, and other biologics that can potentially address unmet medical needs. In particular, the growing interest in antibody-based therapies and immunotherapies has highlighted the importance of efficient drug discovery methods like DNA-encoded libraries.

Technological advancements in genomics and bioinformatics have further fueled the market's growth. As sequencing technologies have become more advanced and cost-effective, the ability to construct large, highly diverse DNA-encoded libraries has improved. The integration of bioinformatics tools has also enhanced the ability to analyze complex data, allowing researchers to optimize the selection of candidates and improve the efficiency of the drug discovery process. These advancements have made DNA-encoded libraries more accessible and effective, driving their adoption across pharmaceutical and biotechnology companies.

In addition, the increasing number of collaborations and partnerships between pharmaceutical companies, academic institutions, and contract research organizations is driving market expansion. These collaborations enable the sharing of resources and expertise, accelerating the development and application of DNA-encoded library technology in drug discovery. The market is also supported by increasing funding from both public and private sectors, as the potential for breakthrough drugs remains high. Together, these factors are creating a conducive environment for the growth and expansion of the DNA-encoded library market.

DNA-encoded Library Market Report Highlights:

  • The services segment led the DNA-encoded library industry, generating the highest revenue in 2024, driven by the increasing outsourcing of drug discovery research.
  • Based on therapeutic area, the oncology segment held the largest revenue share of 38.32% in 2024, primarily due to the high demand for targeted cancer therapies.
  • Based on application, the hit generation/identification segment dominated the market in 2024 with a share of 42.52%, due to the growing need for efficient lead discovery solutions.
  • Based on end use, pharmaceutical and biotechnology companies accounted for the largest revenue share of 42.77% in 2024, primarily due to their extensive investment in drug discovery programs.
  • North America is dominant in the market for DNA-encoded libraries, primarily due to its biotechnology sectors and robust pharmaceutical industry.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Therapeutic Area
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. DNA-Encoded Library Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing Demand for Drug Discovery & Development
      • 3.2.1.2. Advancements in DNA-Encoded Library Technology & AI Integration
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Complexity in Data Management & Analysis
      • 3.2.2.2. High Initial Investment & Technical Challenges
  • 3.3. DNA-Encoded Library Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. DNA-Encoded Library Market: Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global DNA-Encoded Library Market Product & Service Movement Analysis
  • 4.3. Global DNA-Encoded Library Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Products Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.2. Kits & Reagents
      • 4.4.2.1. Kits & Reagents Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.3. Encoded Libraries
      • 4.4.3.1. Encoded Libraries Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.5.2. Design & Synthesis Services
      • 4.5.2.1. Design & Synthesis Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.5.3. Screening Services
      • 4.5.3.1. Screening Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. DNA-Encoded Library Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Therapeutic Area Segment Dashboard
  • 5.2. Global DNA-Encoded Library Market Therapeutic Area Movement Analysis
  • 5.3. Global DNA-Encoded Library Market Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5. Infectious Diseases
    • 5.5.1. Infectious Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.6. Cardiovascular Diseases
    • 5.6.1. Cardiovascular Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.7. Neurological Diseases
    • 5.7.1. Neurological Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.8. Autoimmune Diseases
    • 5.8.1. Autoimmune Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.9. Metabolic Diseases
    • 5.9.1. Metabolic Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.10. Other
    • 5.10.1. Other Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. DNA-Encoded Library Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global DNA-Encoded Library Market Application Movement Analysis
  • 6.3. Global DNA-Encoded Library Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Hit Generation/Identification
    • 6.4.1. Hit Generation/Identification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
  • 6.5. Hit to Lead
    • 6.5.1. Hit to Lead Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
  • 6.6. Hit Validation/Optimization
    • 6.6.1. Hit Validation/Optimization Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
  • 6.7. Others
    • 6.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)

Chapter 7. DNA-Encoded Library Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global DNA-Encoded Library Market End Use Movement Analysis
  • 7.3. Global DNA-Encoded Library Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Academic & Research Institutes Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 7.5. Pharmaceutical & Biotechnology Companies
    • 7.5.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 7.6. Contract Research Organizations
    • 7.6.1. Contract Research Organizations Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 8. DNA-Encoded Library Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Company Market Position Analysis, 2024
  • 9.3. Strategy Mapping
  • 9.4. Participants Overview
    • 9.4.1. Merck KGaA
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product & service benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. GenScript
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product & service benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Pharmaron
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product & service benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. WuXi Biology
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product & service benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Aurigene Pharmaceutical Services
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product & service benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. BOC Sciences
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product & service benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. LGC Bioresearch Technologies
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product & service benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. SPT Labtech Ltd
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product & service benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Life Chemicals
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product & service benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Charles River Laboratories
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product & service benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global DNA-Encoded Library Market, by Region, 2018 - 2030 (USD Million)
  • Table 3 Global DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 4 Global DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 5 Global DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 North America DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 9 North America DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 10 North America DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 13 U.S. DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 14 U.S. DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 U.S. DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Canada DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 17 Canada DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 18 Canada DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Canada DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Mexico DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 21 Mexico DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 22 Mexico DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Mexico DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Europe DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
  • Table 25 Europe DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 26 Europe DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 27 Europe DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Europe DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 UK DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 30 UK DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 31 UK DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 UK DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Germany DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 34 Germany DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 35 Germany DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 Germany DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Italy DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 38 Italy DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 39 Italy DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Italy DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 France DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 42 France DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 43 France DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 France DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Spain DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 46 Spain DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 47 Spain DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 48 Spain DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Sweden DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 50 Sweden DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 51 Sweden DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Sweden DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Denmark DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 54 Denmark DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 55 Denmark DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 Denmark DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 Norway DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 58 Norway DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 59 Norway DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 Norway DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 China DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 67 China DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 68 China DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 China DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Japan DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 71 Japan DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 72 Japan DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Japan DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 74 India DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 75 India DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 76 India DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 77 India DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 78 South Korea DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 79 South Korea DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 80 South Korea DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 South Korea DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Australia DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 83 Australia DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 84 Australia DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 Australia DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Thailand DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 87 Thailand DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 88 Thailand DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Thailand DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 90 Latin America DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
  • Table 91 Latin America DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 92 Latin America DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 93 Latin America DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 Latin America DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 95 Brazil DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 96 Brazil DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 97 Brazil DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 98 Brazil DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 99 Argentina DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 100 Argentina DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 101 Argentina DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 102 Argentina DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 103 Middle East Africa DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
  • Table 104 Middle East Africa DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 105 Middle East Africa DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 106 Middle East Africa DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 107 Middle East Africa DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 108 South Africa DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 109 South Africa DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 110 South Africa DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 111 South Africa DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 116 UAE DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 117 UAE DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 118 UAE DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 119 UAE DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 121 Kuwait DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 122 Kuwait DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Therapeutic Areas
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling for Market Share Assessment
  • Fig. 7 Market formulation & Validation
  • Fig. 8 DNA-Encoded Library Market: Market Outlook
  • Fig. 9 Parent Market Outlook
  • Fig. 10 Related/Ancillary Market Outlook
  • Fig. 11 DNA-Encoded Library Market Driver Impact
  • Fig. 12 DNA-Encoded Library Market Restraint Impact
  • Fig. 13 DNA-Encoded Library Market: Product & Service Movement Analysis
  • Fig. 14 DNA-Encoded Library Market: Product & Service Outlook and Key Takeaways
  • Fig. 15 Products Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Kits & Reagents Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Encoded Libraries Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Design & Synthesis Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Screening Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 DNA-Encoded Library Market: Therapeutic Area Movement Analysis
  • Fig. 24 DNA-Encoded Library Market: Therapeutic Area Outlook and Key Takeaways
  • Fig. 25 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Cardiovascular Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Neurological Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Autoimmune Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Metabolic Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 DNA-Encoded Library Market: Application Movement Analysis
  • Fig. 33 DNA-Encoded Library Market: Application Outlook and Key Takeaways
  • Fig. 34 Hit Generation / Identification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Hit to Lead Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Hit Validation / Optimization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 DNA-Encoded Library Market: End Use Movement Analysis
  • Fig. 39 DNA-Encoded Library Market: End Use Outlook and Key Takeaways
  • Fig. 40 Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Contract Research Organizations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Global DNA-Encoded Library Market: Regional Movement Analysis
  • Fig. 45 Global DNA-Encoded Library Market: Regional Outlook and Key Takeaways
  • Fig. 46 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. Country Dynamics
  • Fig. 48 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Canada Country Dynamics
  • Fig. 50 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico Country Dynamics
  • Fig. 52 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UK Country Dynamics
  • Fig. 55 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Germany Country Dynamics
  • Fig. 57 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 France Country Dynamics
  • Fig. 59 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Italy Country Dynamics
  • Fig. 61 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Spain Country Dynamics
  • Fig. 63 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Denmark Country Dynamics
  • Fig. 65 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Sweden Country Dynamics
  • Fig. 67 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Norway Country Dynamics
  • Fig. 69 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 China Country Dynamics
  • Fig. 72 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Japan Country Dynamics
  • Fig. 74 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 India Country Dynamics
  • Fig. 76 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Thailand Country Dynamics
  • Fig. 78 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 South Korea Country Dynamics
  • Fig. 80 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Australia Country Dynamics
  • Fig. 82 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Brazil Country Dynamics
  • Fig. 85 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Argentina Country Dynamics
  • Fig. 87 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 South Africa Country Dynamics
  • Fig. 90 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Saudi Arabia Country Dynamics
  • Fig. 92 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 UAE Country Dynamics
  • Fig. 94 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait Country Dynamics
  • Fig. 96 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Market Position of Key Market Players